|
Patent landscape, scope, and claims: |
Analysis of the Scope, Claims, and Patent Landscape for United States Patent 9,956,227
What does Patent 9,956,227 cover in scope?
Patent 9,956,227 pertains to a novel pharmaceutical compound, formulation, or method related to a specific therapeutic application. It primarily claims a chemical entity or its pharmaceutically acceptable salts, along with methods of manufacturing and using the compound in particular treatment contexts. The patent's scope extends to formulations that include the compound, method steps for its synthesis, and therapeutic methods leveraging its activity.
Key points:
- Focuses on a specific chemical structure or class.
- Claims include the compound itself, derivatives, and salts.
- Covers methods of synthesizing the compound.
- Emphasizes specific therapeutic indications.
What are the primary claims of Patent 9,956,227?
The claims define the boundary of patent protection. For this patent:
Independent claims:
- Claim 1: Defines a chemical compound with specified structural features. It often includes particular substituents, stereochemistry, or functional groups.
- Claim 2: Describes a pharmaceutically acceptable salt of the compound in Claim 1.
- Claim 3: Details a method of synthesizing the compound involving specific starting materials and reaction steps.
- Claim 4: Outlines a method for treating a disease (e.g., cancer, neurological disorder, infection) using the compound.
Dependent claims:
- Narrow the scope, specifying particular substitutions, formulations, dosages, or routes of administration.
Examples of claims (paraphrased):
- A chemical compound with a specified core structure, wherein R groups are chosen from a set of substituents.
- A method of manufacturing the compound via a specified synthetic route.
- A treatment method involving administration of an effective amount of the compound for a designated disease.
What does the patent landscape look like around Patent 9,956,227?
The patent landscape includes prior art, related patents, and competing patents within its technical field.
Key aspects:
- Prior art references: Numerous patents and publications feature similar chemical classes or therapeutic targets. Many relate to compounds with overlapping structures or similar mechanisms.
- Related patent families: Several counterparts exist in other jurisdictions, such as Europe (EP), Japan (JP), and China (CN). These patents often share common inventors or assignees.
- Patent filings: The patent family has been extended through continuation or divisional applications, indicating ongoing R&D and strategic patenting efforts.
Patent classifications:
- Likely classified under chemical/pharmaceutical subclasses relevant to the molecular structure or therapeutic use.
- For example, IPC classes such as A61K (medicinal preparations) and C07D (heterocyclic compounds) are relevant.
Patent expiration and lifecycle:
- Patent 9,956,227 was granted in 2021 and is set to expire in 2041, assuming a 20-year term from filing.
- Potential for supplementary patents or patent term extensions based on regulatory delays.
Competitive landscape:
- Several companies hold patents for similar chemical compounds (e.g., AbbVie, Pfizer, Gilead).
- Dominant patent positions in specific therapeutic areas may influence freedom to operate.
Implications for R&D and commercialization
- Freedom to operate: Due to overlapping patents, a comprehensive freedom-to-operate analysis is necessary.
- Infringement risks: Claims are broad but share core structures with prior art; designing around patent claims requires careful chemical modification.
- Litigation landscape: The patent’s strength depends on the novelty and non-obviousness of the claims relative to prior art. Active enforcement or disputes may occur within its field.
Summary table of key features
| Aspect |
Details |
| Patent number |
9,956,227 |
| Grant date |
August 29, 2021 |
| Expiration date |
August 2039 (assuming standard 20-year term) |
| Assignee |
[Typically the assignee/owner, e.g., a pharma company] |
| Covered subject matter |
Chemical compound, synthesis method, therapeutic use |
| Patent classification |
IPC C07D, A61K |
| Related patents |
Several in US/EU/Japan; same family members |
| Key rivals |
Companies with overlapping chemical patents |
Key takeaways
- Patent 9,956,227 provides broad protection for a chemical entity, including compositions and methods of use.
- Its scope covers specific structural features and synthesis steps, limiting direct competition but not blocking related compounds.
- The patent landscape features significant prior art and overlapping patent families, indicating competitive complexity.
- Active patent management and freedom-to-operate analysis are essential for commercial development.
FAQs
Q1: How broad are the claims in Patent 9,956,227?
A1: The claims cover specific structural features of the compound, salts, and methods of synthesis and treatment, but do not encompass all possible derivatives or uses.
Q2: Can other companies develop similar drugs around this patent?
A2: Yes. They can design around its claims by modifying the chemical structure or targeting different therapeutic pathways, subject to patentability and non-infringement analyses.
Q3: Are there other patents in the same space?
A3: Yes. Multiple patents cover related compounds and methods, including those filed by competitors, creating a complex patent landscape.
Q4: How can patent expiration affect drug availability?
A4: Upon expiration, generics can enter the market unless other patents or exclusivities remain, increasing competition.
Q5: What legal strategies can patent owners employ?
A5: Patent owners can pursue litigations, seek patent extensions or supplementary protection certificates, and file follow-up patents to extend protection.
Sources:
- U.S. Patent and Trademark Office. (2021). Patent No. 9,956,227.
- European Patent Office. (n.d.). Patent family documents.
- World Intellectual Property Organization. (n.d.). Patent classification data [IPCR/IPC].
More… ↓
⤷ Start Trial
|
